Lucid Resources

Explore topics, news, events, and inspiring insights on Lucid’s blog.

Lucid Genomics joins Compatibility Partnership with Oxford Nanopore Technologies

We are thrilled to announce that Lucid Genomics has joined the Oxford Nanopore Technologies (ONT) partner ecosystem as a validated solution for tertiary analysis of long-read sequencing data.

May 19, 2026

Lucid Genomics joins Co-Marketing Partnership with QIAGEN

We are excited to announce that Lucid Genomics and QIAGEN have entered into a co-marketing partnership. QIAGEN customers gain a direct path to long-read native interpretation through the Lucid Platform.

April 29, 2026

Lucid Genomics joins Compatibility Partnership PacBio

We are thrilled to announce that Lucid Genomics has been named PacBio Compatibility Partner for tertiary analysis. Our platform is recognized as a validated solution for end-to-end long-read genomic data analysis within the PacBio ecosystem.

April 21, 2026

Lucid Genomics won the Public Award at Hack4Hope Paris 2025.

Hack4Hope is organized by Paris Saclay Cancer Cluster (PSCC) and brings together startups, clinicians, researchers and patient advocates to build real solutions for childhood cancer.

December 4, 2025

Product launch Lucid Genome Suite

We hosted our first-ever product launch webinar, and it was an inspiring start

April 15, 2025

Funding by the European Regional Development Fund

Lucid Genomics is now funded by the European Regional Development Fund (EFRE) through the Investitionsbank Berlin (IBB)

March 25, 2025

Achim Geppert as Co-Founder and Chief Commercial Officer

As of February 1st, Achim Geppert joined Lucid Genomics as third Co-Founder and Chief Commercial Officer

March 3, 2025

Lucid Genomics at Festival of Genomics & Biodata 2025

During the FoG 2025 in London, we were able to connect with many experts and demo our software and solutions.

January 31, 2025

Lucid Genomics secures pre-seed funding

We raised €1.3 million in a pre-seed funding round led by Caesar Ventures and other supporters

September 2, 2024

FIND YOUR SOLUTION

Cut through the noise.
Get to the answer.

Whether you're making diagnostic decisions or pushing the boundaries of discovery, Lucid meets you where the data gets complex.

FOR CLINICIANS

Diagnose with confidence.

Explore solutions

FOR RESEARCHERS

Investigate with confidence.

Explore solutions

Publications

AML with complex karyotype: extreme genomic complexity revealed by combined long-read sequencing and Hi-C technology

Acute myeloid leukemia with complex karyotype (CK-AML) is associated with poor prognosis, which is only in part explained by underlying TP53 mutations.

November 10, 2024

Enhancer hijacking at the ARHGAP36 locus is associated with connective tissue to bone transformation

Heterotopic ossification is a disorder caused by abnormal mineralization of soft tissues in which signaling pathways such as BMP, TGFβ, and WNT are known key players in driving ectopic bone formation.

April 11, 2023

TADA - A machine learning tool for functional annotation-based prioritisation of pathogenic CNVs

Few methods have been developed to investigate copy number variants (CNVs) based on their predicted pathogenicity. We introduce TADA, a method to prioritise pathogenic CNVs through …

March 01, 2022

Hi-C identifies complex genomic rearrangements and TAD-shuffling in developmental diseases

Genome-wide analysis methods, such as array comparative genomic hybridization (CGH) and whole-genome sequencing (WGS), have greatly advanced the identification of structural variants (SVs) in the human genome.

June 04, 2020